Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $625

Benzinga Newsdesk www.benzinga.com Positive 65.5%

Neg 0% Neu 0% Pos 65.5%

Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $600 to $625.